“We are racing for One Cure this weekend thanks to the generosity of One Cure fans and supporters David and Maxine Pierce. None of us like cancer, and David and Maxine are helping me to raise awareness, and funds, as we race for One Cure to help all cancer patients.”
Full FDA approval of Tanovea is the first of its kind, offering hope to the owners of tens of thousands of dogs. The Fort Collins company was launched in 2010 through a partnership with Colorado State University’s Flint Animal Cancer Center.
One Cure returns to the No. 14 Ford Mustang for its first race of the 2021 season at Atlanta. The One Cure project is led by the Flint Animal Cancer Center at Colorado State University with a mission to find a cancer cure through research benefiting man’s best friend.
The College of Veterinary Medicine and Biomedical Sciences communications team recently won a Bronze Telly Award for its Staying Human video series in the category of Social Video: Social Impact.
Why did I choose to be the agent of death for my animals? It might seem like a very odd way to express my love... but I knew this act would fulfill our promise to spare them the kind of suffering that causes nightmares.
Inspired by a family's battle against cancer, Dr. Amy MacNeill is developing a viral therapy to treat soft tissue sarcomas like rhabdomyosarcoma.
The Flint Animal Cancer Center acquired a small animal irradiator, which shows promise for helping treat cancer in small companion animals, including hedgehogs, guinea pigs, parrots, and ferrets.
"We’re testing something that is really cutting edge that, if successful, really has the potential to change a lot in terms of human and animal health," said Dr. Doug Thamm, director of clinical research at Flint Animal Cancer Center.
Ivar the dog was born with a hole in his heart and veterinary cardiologists were able to close it with the help of a 3D printer.
VIDEO: A CSU oncologist is researching a vaccination to prevent canine cancer. "The goal of this is really unique in that we are trying to prevent cancer in the first place." -Dr. Doug Thamm